|
REBEn is a peer-reviewed open access journal that has the mission of disseminating nursing and health sciences.
REBEn accepts manuscripts in Portuguese, English, and Spanish. It is published only in electronic and streaming. Content published on REBEn is under license from Creative Commons (CC-BY) Attribution 4.0 International.
Upon acceptance, manuscripts written in Portuguese or Spanish must be translated into English.
Manuscripts should be intended exclusively for REBEn, and their simultaneous submission to another journal(s) is not permitted.
REBEn has a consolidated digital preservation policy together with SciELO.
REBEn endorses open science practices consisting of transparent and accessible knowledge that is shared and developed through collaborative work networks (FOSTER Open Science Definition).
Given this definition and aiming to increase the rigor, responsibility and reproducibility of research in favor of transparency, quality, and speed, according to the TOP (Transparency and Openness Promotion) recommendations, REBEn accepts manuscripts from preprint servers for peer review process.
1.1 Declaration on Ethics and Integrity in Research
REBEn supports the recommendations for conducting, reporting, editting, and publishing scholarly work in medical journals (Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals) of the International Committee of Medical Journal Editors (International Committee of Medical Journal Editors). These recommendations, relating to integrity and ethical standards in conduct and research reporting, are available at URL http://www.icmje.org/urm_main.html.
1.2 Cases that require corrections, retractions and editorial expressions of concern
REBEn adopts the recommendations of the codes of ethical conduct in publication of the Committee on Publication Ethics (COPE).
It also adopts the Ithenticate system for similarity identification. Practices that harm scientific integrity, such as plagiarism, self-plagiarism, data fabrication, redundant publication and undisclosed conflicts of interest, can be identified during the review process or even after publication.
Once identified, they will be taken for evaluation by members of the Editorial Board and will follow the flowchart provided by COPE so that a proper decision can be taken, such as: embargo, suspension of publishing in the journal for a period determined by the Editorial Board, publication of a letter of concern or retraction of the published manuscript, highlighting the reason(s) for retraction.
Authors will be immediately informed of all stages of this process, as well as the final decision.
REBEn encourages the submission of letters to the editor, where readers can present their criticisms and/or request clarification of any doubts raised by an article recently published in the journal.
1.3 Conflict of Interest
REBEn requires that all authors of the manuscript declare any potential sources of conflicts of interest. Any interest or relationship, financial or otherwise, or personal, religious or political beliefs that may be perceived as influencing an author’s objectivity are considered a potential source of conflict of interest. Potential sources of conflict of interest include, but are not limited to: patent or ownership of shares, membership in a company’s board of directors, membership in a company’s advisory board or committee, and consulting or receiving a speaker’s fee. company. The existence of a conflict of interest does not prevent publication. If the authors have no conflict of interest to declare, they must declare it when submitting the manuscript in the Letter to the Editor. It is the responsibility of the corresponding author to review this policy with all the authors, and collectively disclose with the submission ALL the commercial and other pertinent relationships.
The conflict of interest declaration must be informed at the time of submission of the manuscript by the ScholarOne system
1.4 Aprovall of the Research Ethics Council for studies involving humans or animals
REBEn considers condition sine qua non for publication that the submitted manuscripts have complied with the ethical-legal guidelines that involve the elaboration of academic and/or technical-scientific works and research with humans or animals.
In the case of research involving human beings, and in compliance with CNS Resolution 466/2012 the Brazilian author (s) must mention in the manuscript the approval of the project by the Ethics Committee recognized by the Brazilian National Research Ethics Committee of the Brazilian National Health Council (CONEP (Comissão Nacional de Ética em Pesquisa)-CNS (Conselho Nacional de Saúde)), or by an equivalent body, when the research has been carried out in another country.
In experimental research involving animals, Law 11,794,of October 8, 2008, which regulates item VII of paragraph 1 of Article 225 of the Federal Constitution, establishing procedures for the scientific use of animals, and the rules established in Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, National Academy of Sciences, Washington, DC, USA), 1996, and the Ethical Principles in Animal Experimentation of the Brazilian College of Animal Experimentation (COBEA - Colégio Brasileiro de Experimentação Animal), 1991. This information must be included in the method according to the ARRIVE recommendation.
In the METHODS section, indicate whether the research that gave rise to your manuscript was submitted for consideration by the Research Ethics Committee in your country, or provide the justification in case of exemption in the following form:
“The study was conducted in accordance with national and international ethics guidelines and approved by the Research Ethics Council or Committee of [INSTITUTION NAME], whose opinion is attached to this submission. OR “Ethical review and approval was waived for this study, due to REASON (please provide a detailed rationale).”
Declaration of Informed Consent:
Any research article describing a study involving human subjects must contain this statement under METHODS.
“Informed consent was obtained from all subjects involved in the study through [WRITTEN, ONLINE; BETWEEN OTHERS]". OR “Patient consent was waived for REASON (please provide detailed justification).” OR “Not applicable” for studies that do not involve humans.
If deemed necessary, editors may request further information.
1.5 Use of Artificial Intelligence:
Authors should disclose in their manuscript the use of AI and AI-assisted technologies in the writing process by following the instructions below. A statement will appear on the published work. Please note that the authors are responsible for the content of the work.
Dissemination instructions
Authors must disclose the use of generative AI and AI-assisted technologies in the writing process by adding a statement under the METHODS of their manuscript in the main manuscript file. The statement should be placed in a new section titled 'Statement of Generative AI and AI-Assisted Technologies in the Writing Process'.
Disclaimer: During the preparation of this work, the author(s) used [TOOL/SERVICE NAME] for [REASON]. After using this tool/service, the author(s) have revised and edited the content as necessary and have taken full responsibility for the content of the post.
This statement does not apply to the use of basic tools for checking grammar, spelling, references, etc. If there is nothing to disclose, there is no need to add a declaration.
|
